Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitomi Takada

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Journal of Tissue Engineering and Regenerative Medicine|January 30, 2018
Therapeutic effects of a recombinant human collagen peptide bioscaffold with human adipose-derived stem cells on impaired wound healing after radiotherapyTakanobu Mashiko, Hitomi Takada, Szu-Hsien Wu, et al.
Cancer Medicine|October 18, 2016
Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinomaHitomi Takada, Kaoru Tsuchiya, Yutaka Yasui, et al.
Oncology|June 28, 2023
Relationship between Plasma IP-10/CXCL10 Levels and the Initial Therapeutic Response in Patients Treated with Atezolizumab plus Bevacizumab for Unresectable Hepatocellular CarcinomaHitomi Takada, Koji Yamashita, Leona Osawa, et al.
Oncology|December 14, 2022
Prediction of Therapeutic Response Using Contrast-Enhanced Ultrasound in Japanese Patients Treated with Atezolizumab and Bevacizumab for Unresectable Hepatocellular CarcinomaHitomi Takada, Koji Yamashita, Leona Osawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 29, 2024
Elevated nuclear expression of ZHX1 correlates with poor prognosis in hepatocellular carcinoma (HCC): Comparison of nuclear and cytoplasmic distribution of the ZHX family in HCC cellsYu-Hong Ma, Shinya Maekawa, Shinichi Takano, et al.
Tissue Engineering. Part A|May 16, 2020
Hair Regeneration Potential of Human Dermal Sheath Cells Cultured Under Physiological OxygenKoji Kanayama, Hitomi Takada, Natsumi Saito, et al.
Stem Cells Translational Medicine|October 24, 2015
Therapeutic Potential of Human Adipose-Derived Stem/Stromal Cell Microspheroids Prepared by Three-Dimensional Culture in Non-Cross-Linked Hyaluronic Acid GelKazuhide Mineda, Jingwei Feng, Hisako Ishimine, et al.
Diagnostics (Basel, Switzerland)|April 3, 2020
Use of the Serum <i>Wisteria floribunda</i> Agglutinin-Positive Mac2 Binding Protein as a Marker of Gastroesophageal Varices and Liver-Related Events in Chronic Hepatitis C PatientsTsuguru Hayashi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 28, 2025
Rechallenge of Atezolizumab Plus Bevacizumab Therapy in Patients With Unresectable Hepatocellular CarcinomaYuichiro Suzuki, Teiji Kuzuya, Leona Osawa, et al.
Plos One|September 15, 2015
Resistance-Associated NS5A Variants of Hepatitis C Virus Are Susceptible to Interferon-Based TherapyJun Itakura, Masayuki Kurosaki, Mayu Higuchi, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Journal of Tissue Engineering and Regenerative Medicine|January 30, 2018
Therapeutic effects of a recombinant human collagen peptide bioscaffold with human adipose-derived stem cells on impaired wound healing after radiotherapyTakanobu Mashiko, Hitomi Takada, Szu-Hsien Wu, et al.
Cancer Medicine|October 18, 2016
Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinomaHitomi Takada, Kaoru Tsuchiya, Yutaka Yasui, et al.
Oncology|June 28, 2023
Relationship between Plasma IP-10/CXCL10 Levels and the Initial Therapeutic Response in Patients Treated with Atezolizumab plus Bevacizumab for Unresectable Hepatocellular CarcinomaHitomi Takada, Koji Yamashita, Leona Osawa, et al.
Oncology|December 14, 2022
Prediction of Therapeutic Response Using Contrast-Enhanced Ultrasound in Japanese Patients Treated with Atezolizumab and Bevacizumab for Unresectable Hepatocellular CarcinomaHitomi Takada, Koji Yamashita, Leona Osawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 29, 2024
Elevated nuclear expression of ZHX1 correlates with poor prognosis in hepatocellular carcinoma (HCC): Comparison of nuclear and cytoplasmic distribution of the ZHX family in HCC cellsYu-Hong Ma, Shinya Maekawa, Shinichi Takano, et al.
Tissue Engineering. Part A|May 16, 2020
Hair Regeneration Potential of Human Dermal Sheath Cells Cultured Under Physiological OxygenKoji Kanayama, Hitomi Takada, Natsumi Saito, et al.
Stem Cells Translational Medicine|October 24, 2015
Therapeutic Potential of Human Adipose-Derived Stem/Stromal Cell Microspheroids Prepared by Three-Dimensional Culture in Non-Cross-Linked Hyaluronic Acid GelKazuhide Mineda, Jingwei Feng, Hisako Ishimine, et al.
Diagnostics (Basel, Switzerland)|April 3, 2020
Use of the Serum <i>Wisteria floribunda</i> Agglutinin-Positive Mac2 Binding Protein as a Marker of Gastroesophageal Varices and Liver-Related Events in Chronic Hepatitis C PatientsTsuguru Hayashi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 28, 2025
Rechallenge of Atezolizumab Plus Bevacizumab Therapy in Patients With Unresectable Hepatocellular CarcinomaYuichiro Suzuki, Teiji Kuzuya, Leona Osawa, et al.
Plos One|September 15, 2015
Resistance-Associated NS5A Variants of Hepatitis C Virus Are Susceptible to Interferon-Based TherapyJun Itakura, Masayuki Kurosaki, Mayu Higuchi, et al.
Pageof 8